Mastodon

Honda® (Capsules, Tablets and capsules) Instructions for Use

Properties

Dietary supplement.

Glucosamine sulfate is one of the components for the synthesis of hyaluronic acid, which is necessary for stimulating the production of the cartilage matrix and providing its non-specific protection. It has anti-inflammatory properties.

Chondroitin sulfate serves as an additional substrate for the formation of a healthy cartilage matrix. It stimulates the formation of hyaluronan, the synthesis of proteoglycans and type II collagen, and also protects the cartilage tissue matrix from enzymatic cleavage (by suppressing hyaluronidase activity) and from the damaging effects of free radicals. It maintains the viscosity of the synovial fluid, stimulates cartilage repair mechanisms, and suppresses the activity of enzymes (elastases, hyaluronidases) that break down cartilage.

As a result of the action of the combination of glucosamine and chondroitin sulfate, joint mobility improves, the effectiveness of the main therapy increases, and the need for the use of painkillers and anti-inflammatory drugs decreases.

Collagen and hyaluronic acid, which may be part of the products, are contained in large quantities in cartilage, tendons, and synovial fluid. Vitamin C, B vitamins, vitamin E, and trace elements act in accordance with their biological properties.

Scope of Application

Recommended as an additional remedy for inflammatory and degenerative diseases of the joints and spine.

ICD codes

ICD-10 code Indication
M13.9 Arthritis, unspecified
M15 Polyosteoarthritis
M47 Spondylosis
ICD-11 code Indication
FA05 Polyosteoarthritis
FA2Z Inflammatory arthropathies, unspecified
FA8Z Degenerative disease of spine, unspecified

Dosage Regimen

The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen.

Capsules

Individual, depending on the product used.

Side effects

Possible allergic reactions.

Contraindications

Hypersensitivity to the components of the product used.

Use during pregnancy and breastfeeding

Contraindicated for use during pregnancy and breastfeeding.

Special instructions

This is not a medicinal product.

Consult a doctor before using the product.

Do not exceed the recommended dose of the product used.

In children, use only dietary supplements intended for the corresponding age group.

Tablets and capsules

Adults: 2 capsules (tablets) 2 times a day with meals. The duration of intake is at least 30 days.

This is not a medicine.

Contraindications

Individual intolerance to the components, pregnancy, breastfeeding. It is recommended to consult a doctor before use.

Use during pregnancy and breastfeeding

Contraindicated during pregnancy and lactation.

Storage Conditions

Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.

Dispensing Status

Over-the-Counter

Important Safety Information

This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.

Medical Disclaimer

Brand (or Active Substance), Marketing Authorisation Holder, Dosage Form

Marketing Authorization Holder

Evalar, CJSC (Russia)

Dosage Form

Bottle OTC Icon Honda® Capsules

Dosage Form, Packaging, and Product Composition

Capsules 350 mg.

Marketing Authorization Holder

Evalar, CJSC (Russia)

Dosage Forms

Bottle OTC Icon Honda® Capsules
Tablets
Tablets, coated

Dosage Form, Packaging, and Product Composition

Composition glucosamine hydrochloride, chondroitin sulfate, white willow bark extract, burdock root extract, E460, E470, E461, E464, E171, E433, E1521.

Content of biologically active substances per 1 capsule: chondroitin sulfate not less than 80 mg, glucosamine (hydrochloride) not less than 80 mg.

Release form and packaging
Tablets 500 mg. Tablets, coated, 500 mg. Capsules 250 mg.
30 tablets, coated tablets, or capsules per package. 1 package in a cardboard box.

TABLE OF CONTENTS